Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Accounts Payable
$16,873 Mil (As of Mar. 2015)

GlaxoSmithKline PLC's quarterly accounts payable declined from Sep. 2014 ($14,373 Mil) to Dec. 2014 ($13,529 Mil) but then increased from Dec. 2014 ($13,529 Mil) to Mar. 2015 ($16,873 Mil).

GlaxoSmithKline PLC's annual accounts payable increased from Dec. 2012 ($14,969 Mil) to Dec. 2013 ($15,532 Mil) but then declined from Dec. 2013 ($15,532 Mil) to Dec. 2014 ($13,529 Mil).


Definition

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Accts Payable 1,4297,2619,81110,18613,34912,37914,04414,96915,53213,529

GlaxoSmithKline PLC Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
Accts Payable 14,96913,69114,15514,29115,53214,40013,81414,37313,52916,873
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK